Find a Physician

Email this profile
Portrait View Larger

Jeffrey Dunn, MD

Academic Appointments

Contact Information

  • Clinical Offices
    Dept of Neurology 300 Pasteur Dr Rm A343 MC 5325 Stanford, CA 94305
    Tel Work (650) 736-4310 Fax (650) 725-7459
  • Academic Offices
    Personal Information
    Tel (650) 736-4310
    Alternate Contact
    Ana Mezynski Administrative Associate Tel Work 650.736.4310
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Multiple Sclerosis
  • Neuromyelitis Optica
  • Transverse Myelitis
  • Neurology

Academic Appointments

Administrative Appointments

  • Co-Director, Stanford Multiple Sclerosis Center (2008 - present)
  • Director, Neurology Clerkship Program (2009 - present)
  • Chair, MS Education Workgroup, Multiple Sclerosis Section; American Academy of Neurology (2011 - present)
  • Councilor, Executive Committee, Multiple Sclerosis Section; American Academy of Neurology (2010 - present)

Honors and Awards

  • Henry J. Kaiser Family Foundation Award for Excellence in Clinical Teaching, Stanford University School of Medicine (2013)
  • Top Doctors, US News & World Report (2012-2013)
  • AUPN Neurology national recuitment award, Association of University Professors of Neurology (2012)
  • Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine, Stanford University School of Medicine (2011)
  • Excellence in Teaching Award, Stanford University School of Medicine (2011-2012)
  • Excellence in Teaching Award, Stanford University School of Medicine (2010-2011)
View All 12honors and awards of Jeffrey Dunn

Professional Education

Residency: University of Washington Medical Center WA (1993)
Internship: Eastern VA Medical School VA (1990)
Medical Education: Temple University School of Medicine PA (1989)
Board Certification: Neurology, American Board of Psychiatry and Neurology (1994)
Residency: University of Washington, Neurology (1993)
M.D.: Temple University, Medicine (1989)
View All 7

Community and International Work



Scientific Focus

Current Research and Scholarly Interests

Translational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO, recently including trials of alemtuzumab, oral sphingosine 1 phosphate inhibition, NIH CombiRx and Biomarkers, Subcutaneous Tovaxin in Subjects with CIS, Subcutaneous Daclizumab, NC-100 Novantrone induction, dose ranging GA pilot trial, natalizumab safety and tolerability monitoring; and sub-investigation of Fampridine SR (approved 1/10 brand name Ampyra).


Publication tag cloud

Publication Topics

View All 23

Stanford Medicine Resources:

Footer Links: